NCT04122222View on ClinicalTrials.gov

Immune Response to Influenza Vaccine in ESRD Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

July 20, 2018

Study Completion Date

July 20, 2018

Conditions
ImmunologyNephrology
Interventions
BIOLOGICAL

Influenza vaccine

A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly.

All Listed Sponsors
collaborator

Bhumirajanagarindra Kidney Institute, Thailand

OTHER

collaborator

Ministry of Health, Thailand

OTHER_GOV

lead

Mahidol University

OTHER

NCT04122222 - Immune Response to Influenza Vaccine in ESRD Patients | Biotech Hunter | Biotech Hunter